Skip to content
North Circle

The Zimbabwean Government Declines ‘One-Sided’ US Health Aid Package Due to Information Apprehensions

Medical aid illustration
The offered American financial assistance would have supported programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a substantial US health deal valued at 367 million US dollars (272 million pounds) over five years due to the United States' insistence on sensitive data.

The decision became public following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa deemed the agreement was "lopsided".

A government spokesman has since explained that the United States was requesting genetic material for scientific study and commercial purposes but was not willing to share the resulting advantages from future vaccines.

"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has urged more dialogue to find a agreement acceptable to both sides so the country's vital HIV treatment initiative can be sustained.

Wider Context

Zimbabwe's decision follows a similar case in neighbouring Kenya, where a court blocked a related health funding agreement after concerns were raised about the security of Kenyans' health data.

After returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.

USAID had overseen aid for the American government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government agreements to enhance transparency and responsibility.

As per statements, 16 nations in Africa have to date signed similar health pacts, representing more than $18.3bn in new funding.

Details of the Rejected Agreement

This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this cooperation might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through US-supported initiatives," Tremont said.

However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".

"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that could result from that shared data," he stated.

"Effectively, our country would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our citizens should a future disease outbreak emerge."

Sovereignty and International Frameworks

He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending systems already established via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.

"This mechanism is intended to guarantee that when a country provides its information, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.

"We encourage continued discussions with our American counterparts on how subsequent co-operation might be structured in a manner that respects the sovereignty and interests of each country."

Health Experts Reaction

Medical experts stated it recognised the government's concerns, but recommended that talks should continue since much of the nation's Aids initiatives relied on external financing.

"Where specific concerns exist, including those relating to information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group added.

This impasse emphasises the continuing challenges between receiving much-needed international aid and protecting a country's data in an ever more interconnected world.

The writer

Pam Medina

A seasoned outdoor guide and writer passionate about sustainable travel and wilderness conservation.

North Circle

Type to search articles.